Bill Sponsor
House Bill 3584
116th Congress(2019-2020)
LAB Act
Introduced
Introduced
Introduced in House on Jun 27, 2019
Overview
Text
Introduced
Jun 27, 2019
Latest Action
Jun 28, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3584
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
California
Democrat
California
Republican
California
Democrat
California
Democrat
California
Democrat
California
Democrat
Connecticut
Republican
Florida
Republican
Georgia
Democrat
Georgia
Republican
Illinois
Republican
Kentucky
Democrat
Kentucky
Democrat
Minnesota
Republican
Minnesota
Democrat
Mississippi
Republican
Missouri
Republican
Missouri
Republican
Missouri
Republican
Nebraska
Democrat
New Jersey
Democrat
New Jersey
Democrat
New Jersey
Democrat
New Jersey
Democrat
New Jersey
Democrat
New York
Democrat
North Carolina
Republican
North Carolina
Democrat
North Carolina
Republican
North Carolina
Republican
North Carolina
Republican
North Carolina
Republican
North Carolina
Republican
North Carolina
Democrat
Oklahoma
Democrat
Pennsylvania
Republican
Pennsylvania
Democrat
Pennsylvania
Democrat
Pennsylvania
Democrat
Pennsylvania
Republican
Pennsylvania
Republican
West Virginia
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Laboratory Access for Beneficiaries Act or the LAB Act

This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare & Medicaid Services (CMS) for purposes of determining Medicare payment rates. The CMS must also contract with the National Academies of Sciences, Engineering, and Medicine to evaluate the methodology used to determine a specified laboratory fee schedule.

Text (1)
June 27, 2019
Actions (3)
06/28/2019
Referred to the Subcommittee on Health.
06/27/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
06/27/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:50:48 PM